{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:08:37Z","timestamp":1790100517596,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2022-10-013"],"award-info":[{"award-number":["2022-10-013"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-2310710"],"award-info":[{"award-number":["NCC-2310710"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2610400"],"award-info":[{"award-number":["2610400"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jhepr.2026.102032","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:05:11Z","timestamp":1789142711000},"page":"102032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of seronegativity to HBV vaccine in infants of HBsAg-positive mothers in a national prevention program"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-7104","authenticated-orcid":false,"given":"Moran","family":"Ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naradi","family":"Baduge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-7904","authenticated-orcid":false,"given":"Jong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.102032_bib1","unstructured":"World Health Organization Western Pacific Regional Office. Significant progress in controlling hepatitis B through national vaccination programs in the Western Pacific Region. https:\/\/data.wpro.who.int\/world-hepatitis-day-2023. Last Accessed January 20, 2026."},{"key":"10.1016\/j.jhepr.2026.102032_bib2","unstructured":"World Health Organization. Global Hepatitis Report 2024: action for access in low- and middle-income countries. Geneva: WHO, 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672. Last Accessed January 20, 2026."},{"issue":"Suppl 2","key":"10.1016\/j.jhepr.2026.102032_bib3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1136\/gut.38.Suppl_2.S18","article-title":"Epidemiology of hepatitis B infection in the Western Pacific and South East Asia","volume":"38","author":"Gust","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2026.102032_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM197504102921503","article-title":"Vertical transmission of hepatitis B antigen in Taiwan","volume":"292","author":"Stevens","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2026.102032_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhepr.2026.102032_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00006454-199104000-00007","article-title":"The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers","volume":"10","author":"Lee","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhepr.2026.102032_bib7","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.vaccine.2017.06.019","article-title":"Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China","volume":"35","author":"Wang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102032_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3350\/cmh.2025.0214","article-title":"Factors associated with hepatitis B mother-to-child transmission in a national prevention program","volume":"31","author":"Ki","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102032_bib9","unstructured":"Centers for Disease Control and Prevention. Hepatitis B. In: Hall E, Wodi AP, Hamborsky J, Morelli V, Schillie S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 14th ed. Washington, D.C.: Public Health Foundation, 2021:143-163."},{"key":"10.1016\/j.jhepr.2026.102032_bib10","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jhepr.2026.102032_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"RR-2","key":"10.1016\/j.jhepr.2026.102032_bib12","first-page":"1","article-title":"Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee","volume":"39","year":"1990","journal-title":"MMWR Recomm Rep"},{"issue":"RR-13","key":"10.1016\/j.jhepr.2026.102032_bib13","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jhepr.2026.102032_bib14","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.vaccine.2014.01.099","article-title":"Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women","volume":"32","author":"Ko","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102032_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jvh.12694","article-title":"A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China","volume":"24","author":"Yonghao","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2026.102032_bib16","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2020.05.044","article-title":"Impact of the National Perinatal Hepatitis B Prevention Programme in the Republic of Korea: a retrospective registry-based cohort study","volume":"38","author":"Yang","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102032_bib17","first-page":"168","article-title":"Effect of telbivudine on infants born to HBsAg-positive mothers with non-\/hypo-response to hepatitis B vaccine during their second and third trimesters of pregnancy","volume":"38","author":"Xu","year":"2017","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.jhepr.2026.102032_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2029259","article-title":"Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine","volume":"18","author":"Li","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jhepr.2026.102032_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-019-1560-1","article-title":"Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth","volume":"574","author":"Shao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2026.102032_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2015.07.040","article-title":"Cesarean section and disease associated with immune function","volume":"137","author":"Kristensen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhepr.2026.102032_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/gutjnl-2012-303249","article-title":"Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section","volume":"63","author":"Jakobsson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2026.102032_bib22","first-page":"899","article-title":"Vaginal delivery and breastfeeding benefit infant immune response to hepatitis B vaccine: a prospective cohort study","volume":"11","author":"Liu","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2026.102032_bib23","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1038\/s41467-022-34155-2","article-title":"Mode of delivery modulates the intestinal microbiota and impacts the response to vaccination","volume":"13","author":"de Koff","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2026.102032_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1203\/01.PDR.0000130473.30874.B6","article-title":"Labor promotes neonatal neutrophil survival and lipopolysaccharide responsiveness","volume":"56","author":"Molloy","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jhepr.2026.102032_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184748","article-title":"Surge of immune cell formation at birth differs by mode of delivery and infant characteristics-A population-based cohort study","volume":"12","author":"Schlinzig","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.102032_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajog.2012.08.009","article-title":"Cesarean section and development of the immune system in the offspring","volume":"208","author":"Cho","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jhepr.2026.102032_bib27","unstructured":"American Academy of Pediatrics (AAP). Hepatitis B. In: Peter G, ed. Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove, IL: AAP, 1997:247-260."},{"key":"10.1016\/j.jhepr.2026.102032_bib28","unstructured":"The Korean Pediatric Society (KPS). In: Kang JH, ed. Immunization Guideline: 2002 Report of the Committee on Infectious Diseases. 5th ed. Seoul: KPS, 2002:48-60."},{"key":"10.1016\/j.jhepr.2026.102032_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amepre.2020.03.009","article-title":"Immunogenicity of hepatitis B vaccine in preterm or low birth weight infants: a meta-analysis","volume":"59","author":"Fan","year":"2020","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jhepr.2026.102032_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vaccine.2017.11.037","article-title":"The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: a prospective cohort study","volume":"36","author":"Wei","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102032_bib31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15585\/mmwr.mm6439a6","article-title":"Update: shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers","volume":"64","author":"Schillie","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jhepr.2026.102032_bib32","unstructured":"Korea Disease Control and Prevention Agency (KDCA). Hepatitis B Perinatal Infection Prevention Program. KDCA web site, <https:\/\/nip.kdca.go.kr\/irhp\/index.html>. Accessed 20 January 2026."},{"key":"10.1016\/j.jhepr.2026.102032_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127565","article-title":"Influencing factors and trends in post-vaccination serologic testing completion rates among infants born to HBsAg-positive mothers in Guangdong Province, 2021-2023","volume":"62","author":"Gao","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102032_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/jvh.13581","article-title":"Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants: a 5-year prospective study in Zhejiang Province, China (2016-2020)","volume":"28","author":"Zhou","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2026.102032_bib35","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.vaccine.2017.06.019","article-title":"Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China","volume":"35","author":"Wang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102032_bib36","first-page":"273","article-title":"Certification for achieving the regional goal of hepatitis B control in Korea","volume":"1","year":"2008","journal-title":"Public Health Wkly Rep"},{"key":"10.1016\/j.jhepr.2026.102032_bib37","unstructured":"World Health Organization (WHO). Hepatitis B vaccination coverage in the Republic of Korea. https:\/\/immunizationdata .who.int\/global\/wiise-detail-page\/hepatitis-b-vaccination-coverage?CODE=KOR &ANTIGEN=HEPB3&YEAR=. Last Accessed January 20, 2026."},{"key":"10.1016\/j.jhepr.2026.102032_bib38","first-page":"1548","article-title":"National childhood vaccination coverage among children aged 1\u20133 and 6 years in Korea, 2018","volume":"12","author":"Lee","year":"2019","journal-title":"Public Health Wkly Rep"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:34:27Z","timestamp":1790098467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926003034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S2589555926003034"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102032","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of seronegativity to HBV vaccine in infants of HBsAg-positive mothers in a national prevention program","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"102032"}}